Associate Professor of Surgery, Massachusetts General Hospital
General Surgery
Dr. Sareh Parangi, MD
|
|
Give Review
Sareh Parangi works in the field of General Surgery. She went to Columbia University College of Physicians & Surgeons. Columbia University College of Physicians & Surgeons is a top medical college. Columbia University College of Physicians & Surgeons is ranked 8 in research and 52 in primary care medicine She received awards:"Regional Top Doctor", "Fellow (FACS)" and "Super Doctor". Sareh Parangi is a published physician as well. She has 75 publications published. The latest was: Inhibition of prostate cancer neovascularization and growth by urokinase-plasminogen activator receptor blockade. Dr. Sareh Parangi accepts all Medicare patients.
Publications
- Translaryngeal vocal cord ultrasound: Ready for prime time.
- Pediatric Thyroidectomy in a high volume Thyroid surgery center: Risk factors for postoperative hypocalcemia.
- Combined BRAFV600E- and SRC-inhibition induces apoptosis, evokes an immune response and reduces Tumor growth in an immunocompetent orthotopic mouse model of anaplastic...
- The Role of Genetic Markers in the Evaluation and Management of Thyroid Nodules.
- A potential role for immunotherapy in Thyroid cancer by enhancing NY-ESO-1 cancer antigen expression.
- The Next Generation of Orthotopic Thyroid Cancer Models: Immunocompetent Orthotopic Mouse Models of BRAFV600E-Positive Papillary and Anaplastic Thyroid Carc...
- Potential role of 5-Aza-2'-deoxycytidine induced MAGE-A4 expression in immunotherapy for anaplastic Thyroid cancer.
- Surgery for Graves' Disease: a 25-year perspective.
- The vascular permeabilizing factors histamine and serotonin induce angiogenesis through TR3/Nur77 and subsequently truncate it through thrombospondin-1.
- Management of Thyroid nodules with atypical cytology on fine-needle aspiration biopsy.
- BRAF(V600E) status adds incremental value to current risk classification systems in predicting papillary Thyroid carcinoma recurrence.
- Diagnostic yield of nondiagnostic Thyroid nodules is not altered by timing of repeat biopsy.
- Thyroid lobe ablation with radioactive iodine as an alternative to completion Thyroidectomy after hemiThyroidectomy in patients with follicular Thyroid carcinoma: long...
- Blocks to Thyroid cancer cell apoptosis can be overcome by inhibition of the MAPK and PI3K/AKT pathways.
- Late Intervention with anti-BRAFV600E Therapy Induces Tumor Regression in an Orthotopic Mouse Model of Human Anaplastic Thyroid Cancer.
- Preoperative basal calcitonin and tumor stage correlate with postoperative calcitonin normalization in patients undergoing initial surgical management of Medullary thy...
- Bilaterality in papillary Thyroid carcinoma: does it influence prognosis?
- Medical and surgical risks in Thyroid surgery: lessons from the NSQIP.
- BRAF(V600E) and microenvironment in Thyroid cancer: a functional link to drive cancer progression.
- Targeting BRAFV600E with PLX4720 displays potent antimigratory and anti-invasive activity in preclinical models of human Thyroid cancer.
- The BRAFV600E mutation: what is it really orchestrating in Thyroid cancer?
- Overcoming obstacles to setting up office-based ultrasound for evaluation of Thyroid and paraThyroid diseases.
- Case records of the Massachusetts General Hospital: Case 38-2010: a 13-year-old girl with an enlarging neck mass.
- Summary statement: utility of molecular marker testing in Thyroid cancer.
- Thyroidectomy with neoadjuvant PLX4720 extends survival and decreases tumor burden in an orthotopic mouse model of anaplastic Thyroid cancer.
- Accuracy of 4-dimensional computed tomography in poorly localized patients with primary hyperparaThyroidism.
- Resident/fellow assistance in the operating room for endocrine surgery in the era of fellowships.
- Surgical implications of B-RafV600E mutation in fine-needle aspiration of Thyroid nodules.
- B-Raf(V600E) and thrombospondin-1 promote Thyroid cancer progression.
- Surgical drains can be safely avoided in lateral neck dissections for papillary Thyroid cancer.
- Clinical and cytological features predictive of malignancy in Thyroid follicular neoplasms.
- A novel orthotopic mouse model of human anaplastic Thyroid carcinoma.
- Thyroid surgery in octogenarians is associated with higher complication rates.
- Thrombospondin-1 modulates vascular endothelial growth factor activity at the receptor level.
- When initial postexcision PTH level does not fall appropriately during paraThyroidectomy: what to do next?
- A double hit to kill Tumor and endothelial cells by TRAIL and antiangiogenic 3TSR.
- Role of B-Raf(V600E) in differentiated Thyroid cancer and preclinical validation of compounds against B-Raf(V600E).
- ParaThyroid carcinoma and neurofibromatosis.
- Quantification of vascular endothelial Cell apoptosis in vivo.
- Adeno-associated virus-mediated antiangiogenic gene therapy with thrombospondin-1 type 1 repeats and endostatin.
- Hyalinizing trabecular adenoma--an uncommon Thyroid tumor frequently misdiagnosed as papillary or medullary Thyroid carcinoma.
- Surgical gastrointestinal disorders during pregnancy.
- The gene expression and activity of calpains and the muscle wasting-associated ubiquitin ligases, atrogin-1 and MuRF1, are not altered in patients with primary hyperpa...
- Image of the month. Enterolithotomy.
- Continuous administration of the three thrombospondin-1 type 1 repeats recombinant protein improves the potency of therapy in an orthotopic human pancreatic Cancer model.
- Carcinoid Tumors in the breast.
- Image of the month: acute and chronic choleCystitis with abscess formation.
- Partial Thyroidectomy: illustrated reflections for surgical residents.
- Preoperative evaluation of Thyroid nodules with 18FDG-PET/CT.
- Antiangiogenic treatment with three thrombospondin-1 type 1 repeats versus gemcitabine in an orthotopic human pancreatic Cancer model.
- Angiogenesis in benign and malignant Thyroid disease.
- Antiangiogenic treatment with the three thrombospondin-1 type 1 repeats recombinant protein in an orthotopic human pancreatic Cancer model.
- The Thyroid incidentaloma: an increasingly frequent consequence of radiologic imaging.
- Multiple signaling is involved in endostatin-mediated apoptosis in ECV 304 endothelial Cells.
- Thyroid incidentalomas: a new epidemic.
- Effect of rapamycin alone and in combination with antiangiogenesis therapy in an orthotopic model of human pancreatic Cancer.
- Hemorrhagic cholecystitis simulating gallbladder Carcinoma.
- Management of Thyroid incidentalomas.
- Laparoscopic adrenalectomy for pheochromocytoma.
- Best cases from the AFIP: paraganglioma of the organs of Zuckerkandl.
- Requirement of different signaling pathways mediated by insulin-like growth factor-I receptor for proliferation, invasion, and VPF/VEGF expression in a pancreatic carc...
- False positive 99mTc sestamibi scans in patients with osteitis fibrosa Cystica and brown tumours.
- HyperparaThyroidism after Thyroid surgery and autotransplantation of histologically normal paraThyroid glands.
- Inhibition of prostate Cancer neovascularization and growth by urokinase-plasminogen activator receptor blockade.
- Oncogenic H-ras stimulates Tumor angiogenesis by two distinct pathways.
- Inhibition of angiogenesis and breast Cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol.
- Antiangiogenic therapy of transgenic mice impairs de novo Tumor growth.
- Tumor suppressor loci on mouse chromosomes 9 and 16 are lost at distinct stages of Tumorigenesis in a transgenic model of islet cell carcinoma.
- A strategy to discover circulating angiogenesis inhibitors generated by human Tumors.
- Variant surface glycoprotein gene expression site switches in Trypanosoma brucei.
- Role of calcium in mediating action of carbachol in T84 Cells.
- Strength of laser vascular fusion: preliminary observations on the role of thrombus.
- Tissue soldering by use of indocyanine green dye-enhanced fibrinogen with the near infrared diode laser.
- Hepatobiliary complications of polyarteritis nodosa.
Schools
Columbia University College Of Physicians and Surgeons
Children39s Hospital Boston
Columbia University
Procedures Preformed
- Lymph Node Biopsy or Excision
- ParaThyroid Surgery
- ParaThyroidectomy
- Peripheral Artery Catheterization
- View All
Conditions Treated
- Abnormal Thyroid
- Follicular Thyroid Cancer
- Goiter
- Hashimoto's Disease
- View All
Doctors Specialties
- General Surgery
- Thyroid Disorders
Accepted Insurances
Awards
- Regional Top Doctor
- Fellow (FACS)
- Super Doctor
Education
-
UCSF -
Columbia University College of Physicians & Surgeons
Hospital
-
Beth Israel Deaconess Medical Center -
Mount Auburn Hospital -
Massachusetts General Hospital
Drug Facts
| NPI NUMBER | 1407893084 | |
| NPPES Provider LastName | PARANGI | |
| NPPES Provider FirstName | SAREH | |
| NPPES Provider ZIPCode | 02215 | |
| NPPES Provider State | MA | |
| Specialty Description | General Surgery | |
| Total Claim Count | 37.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1407893084 |
| Last Name Of The Provider | PARANGI |
| First Name Of The Provider | SAREH |
| View All |
Similar Doctors
|
Dr. Abraham Lebenthal, MD
 This Doctor is OpenDoctor Recommended.
|
|
Emily E. Talmich, PA-C |
|
|
Dr. Joel T. Adler, MD |
|
|
Dr. Elisabeth Tracy, MD |
|
|
Dr. Jennifer A. Wargo, MD
This Doctor is OpenDoctor Recommended.
|